Increased Prevalence Of Infectious Diseases Fuels Growth In The Plant-Based Vaccine Market: The Driving Engine Behind Plant-Based Vaccines Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Plant-Based Vaccines Market Size Growth Forecast: What to Expect by 2025?
The market size for plant-based vaccines has seen significant growth in the past few years. It is projected to expand from $1.66 billion in 2024 to $1.83 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. The growth experienced in the historic period can be linked to challenges associated with traditional vaccine production, the demand for more cost-effective vaccine production, the rise of plant molecular farming, a decrease in allergenic potential, and the application of synthetic biology.

How Will the Plant-Based Vaccines Market Size Evolve and Grow by 2029?
The market for plant-based vaccines is predicted to experience a swift expansion in the coming years, ascending to a value of $2.79 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 11.1%. The projected growth during the forecast period is due to factors such as readiness for pandemics, worldwide health protection, broadening of vaccine applications, and the adoption by the pharmaceutical industry. Notable trends for the forecasted period encompass advancements in plant biotechnology, environmentally sustainable practices, incorporation of artificial intelligence and machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

What Drivers Are Propelling the Growth of Plant-Based Vaccines Market Forward?
The plant-based vaccine market is expected to expand due to the widespread nature of infectious diseases. These diseases are primarily caused by harmful pathogens such as bacteria, viruses, fungi, or parasites. Traditional and modern medicine utilizes plant-based vaccines to create safe, effective, stable, and affordable preventative measures, vaccines, and treatments for a variety of health conditions, including infectious diseases. For example, the Global Tuberculosis Report by the World Health Organization, a global health agency based in Switzerland, revealed in October 2022 that the global rate of tuberculosis (TB) was projected to be 10.6 million cases, at a rate of 134 cases per 100,000 population. The Southeast Asia region reported the highest percentage of TB cases, contributing 45% to the overall figure, followed by Africa contributing 23%. Hence, the wide occurrence of infectious diseases is spurring the growth of the plant-based vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

Which Emerging Trends Are Transforming the Plant-Based Vaccines Market in 2025?
One of the prominent trends observed in the plant-based vaccine market is the emphasis on product innovation. To stay competitive, leading firms in the market are concentrating on creating cutting-edge products. As an example, in February 2022, Medicago Inc, a Canadian biopharma company, and UK-based GSK PLC, a biotech and pharmaceutical firm, announced that their COVID-19 vaccine, COVIFENZ, received approval from Health Canada. The COVIFENZ vaccine, being the inaugural plant-based, recombinant, adjuvanted vaccine using virus-like particles (VLP) for COVID-19, is a significant market development. The vaccine employs the COVID-19-like particle (CoVLP) technology and is composed of recombinant spike (S) glycoproteins, which are presented as virus-like particles (VLPs).

What Are the Key Segments in the Plant-Based Vaccines Market?
The plant-based vaccines market covered in this report is segmented -

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types
2) By Source: Tobacco Plant, Maize, Potato, Other Sources
3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:
1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines
2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines
3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines
4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

Who Are the Key Players Shaping the Plant-Based Vaccines Market's Competitive Landscape?
Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

What Geographic Markets Are Powering Growth in the Plant-Based Vaccines Market?
North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12144

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.